A Novel Type of Blood Biomarker: Distinct Changes of Cytokine-Induced STAT Phosphorylation in Blood T Cells Between Colorectal Cancer Patients and Healthy Individuals
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Background: Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths worldwide. Although early diagnosis and treatment is the most successful strategy for improving patient survival, feasible and sensitive blood biomarkers for CRC screening remain elusive. Methods: Sixty-five CRC patients and thirty-three healthy individuals were enrolled. Peripheral blood (PB) and tumor tissues from CRC patients, and PB from healthy individuals were subjected to immunophenotyping and phospho-flow analysis of cytokine-induced phosphorylated STAT (CIPS). Logistic regression was used as a classifier that separates CRC patients from healthy individuals. Results: The proportion of regulatory T cells was increased in PB from CRC patients compared to PB from healthy individuals (p < 0.05). Interestingly, peripheral T cells share several cytokine-induced phosphorylated STAT (CIPS) signatures with T cells from CRC tumor-sites. Additionally, a classifier was made using two signatures distinct between T cells from CRC patients and T cells from healthy individuals. The AUCs (area under curves) of the classifier were 0.88 in initial cohort and 0.94 in the additional validation cohort. Overall AUC was 0.94 with sensitivity of 91% and specificity of 88%. Conclusion: This study highlights that immune cell signatures in peripheral blood could offer a new type of biomarker for CRC screening.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Classification and Regression by randomForest
Liaw, A. I., & Wiener, M. C. (2007) · Cited by 18,594
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737 · cited 1×
“IL-10 is an immunosuppressive cytokine produced by variable immune cells, especially Treg cells [22], which are rich in TILs in our study.”
BackgroundDetection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., Bartlett, B. R., Wang, H., Luber, B., Alani, R. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007094 · Cited by 5,067
ROCR: visualizing classifier performance in R
Sing, T., Sander, O., Beerenwinkel, N., & Lengauer, T. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti623 · Cited by 3,200 · cited 1×
“The receiver operating characteristic (ROC) curve was plotted, and the area under curve (AUC) was calculated using the ROCR package [26].”
MethodZhou, L., Ivanov, I. I., Spolski, R., Min, R., Shenderov, K., Egawa, T., Levy, D. E., Leonard, W. J., & Littman, D. R. (2007) · Nature Immunology · doi:10.1038/ni1488 · Cited by 2,141 · cited 1×
“reported that the effect of IL-6 on Th cells depends on STAT3, which is related to Th17 cell differentiation [21].”
Backgroundgplots: Various R Programming Tools for Plotting Data
Warnes, G. R., Bolker, B., Bonebakker, L., Gentleman, R., Huber, W., Liaw, A., Lumley, T., Maechler, M., Magnusson, A., Moeller, S., et al. (2005) · CRAN: Contributed Packages · doi:10.32614/cran.package.gplots · Cited by 1,228
Best, M. G., Sol, N., Kooi, I., Tannous, J., Westerman, B. A., Rustenburg, F., Schellen, P., Verschueren, H., Post, E., Koster, J., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.09.018 · Cited by 916 · cited 2×
“Recently, mRNA profiling of tumor-educated platelets (TEP) from cancer patients was suggested as a promising strategy for early detection, with good sensitivity and specificity [9].”
BackgroundCirculating tumour cells in cancer patients: challenges and perspectives
Pantel, K., & Alix-Panabières, C. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.07.001 · Cited by 815 · cited 1×
“Specific strategies included signal detection of circulating tumor cells (CTC), circulating tumor DNA (ctDNA), or exosomes [7,8].”
BackgroundCirculating Tumor DNA as a Liquid Biopsy for Cancer
Heitzer, E., Ulz, P., & Geigl, J. B. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2014.222679 · Cited by 767 · cited 1×
“In addition, there remain significant economic barriers, owing to testing costs [12].”
BackgroundBeyer, M., & Schultze, J. L. (2006) · Blood · doi:10.1182/blood-2006-02-002774 · Cited by 732 · cited 2×
“Furthermore, decreased T-cell response to cytokines might be related to increased cytokine consumption owing to increased regulatory T cells with a high affinity for IL-2 receptors [13,15].”
BackgroundZauber, A. G., Lansdorp-Vogelaar, I., Knudsen, A. B., Wilschut, J., van Ballegooijen, M., & Kuntz, K. M. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-9-200811040-00244 · Cited by 581 · cited 1×
“Although early detection of CRC is important for reducing mortality [3], only 65% of the average-risk population in USA was reportedly compliant with CRC screening, including fecal occult blood testing (FOBT) and colonoscopy [4].”
BackgroundVital signs: colorectal cancer screening test use--United States, 2012.
(2013) · PubMed Central · Cited by 431
Finbloom, D. S., & Winestock, K. D. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1079 · Cited by 421 · cited 1×
“IL-10 stimulates STAT3 phosphorylation and stimulates the immunosuppressive environment [17,18].”
BackgroundTumor Cell Dissemination: Emerging Biological Insights from Animal Models and Cancer Patients
Kang, Y., & Pantel, K. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.04.017 · Cited by 421 · cited 1×
“Methods used to detect CTC are of little use for tumor types having tumor cells with no tendency for extravasation [10].”
MethodIL-7 Engages Multiple Mechanisms to Overcome Chronic Viral Infection and Limit Organ Pathology
Pellegrini, M., Calzascia, T., Toe, J. G., Preston, S. P., Lin, A. E., Elford, A. R., Shahinian, A., Lang, P. A., Lang, K. S., Morre, M., et al. (2011) · Cell · doi:10.1016/j.cell.2011.01.011 · Cited by 310 · cited 1×
“, NFAT or SOCS3, which is related with IL-6 responsiveness [14,19,20].”
BackgroundIL10 and PD-1 Cooperate to Limit the Activity of Tumor-Specific CD8+ T Cells
Sun, Z., Fourcade, J., Pagliano, O., Chauvin, J.-M., Sander, C., Kirkwood, J. M., & Zarour, H. M. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3016 · Cited by 198 · cited 1×
“reported that CD8+ TILs present in tumor site upregulate IL-10R and PD-1, and that PBMCs of melanoma patients produce IL-10, which limits the proliferation and survival of IL10R+ tumor antigen-specific CD8+ T cells [23].”
BackgroundSTATs: An Old Story, Yet Mesmerizing
Saeid, A., Saki, N., Ahmadvand, M., Asghari, F., Salari, F., & Rahim, F. (2016) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 124
The tumour trail left in blood
Chi, K. R. (2016) · Nature · doi:10.1038/532269a · Cited by 101 · cited 1×
“In cases using exosomes, distinguishing between normal and tumor-cell-derived exosomes is difficult, as both show wide variation in size [11].”
BackgroundIL-6 trans-Signaling-Dependent Rapid Development of Cytotoxic CD8+ T Cell Function
Böttcher, J. P., Schanz, O., Garbers, C., Zaremba, A., Hegenbarth, S., Kurts, C., Beyer, M., Schultze, J. L., Kastenmüller, W., Rose-John, S., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.008 · Cited by 98 · cited 2×
“In another study, hyper-IL-6 treatment, in combination with anti-CD3/CD28-coated microbeads, induced p-STAT3 in T cells, indicating that hyper-IL-6 initiates an as-yet-undefined signaling cascade related to effector T-cell differentiation [19].”
BackgroundImperiale, T. F., Monahan, P. O., Stump, T. E., Glowinski, E. A., & Ransohoff, D. F. (2015) · Annals of Internal Medicine · doi:10.7326/m14-1720 · Cited by 96 · cited 1×
“However, FOBT suffers from low sensitivity [5], and colonoscopy from increased risks of complication [6] and from poor compliance due to inconvenience.”
BackgroundZhu, M., Xi Tao, X. U., Nie, F., Tong, J. L., Shu Dong, X. I. A. O., & Ran, Z. H. (2010) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2010.00430.x · Cited by 95 · cited 1×
“However, FOBT suffers from low sensitivity [5], and colonoscopy from increased risks of complication [6] and from poor compliance due to inconvenience.”
BackgroundState Disparities in Colorectal Cancer Mortality Patterns in the United States
Naishadham, D., Lansdorp‐Vogelaar, I., Siegel, R. L., Cokkinides, V. E., & Jemal, A. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0250 · Cited by 94 · cited 1×
“Colorectal cancer (CRC) is the third most commonly diagnosed cancer in men and second in women [1,2].”
BackgroundMechanism of T cell exhaustion in a chronic environment
Jin, H.-T., Jeong, Y. H., Park, H.-J., & Ha, S. (2011) · BMB Reports · doi:10.5483/bmbrep.2011.44.4.217 · Cited by 73 · cited 3×
“Under conditions of antigen-persistence by either infection or cancer, loss of T-cell function could occur in a progressive manner through T-cell exhaustion [14].”
BackgroundSTATs: An Old Story, Yet Mesmerizing.
Abroun, S., Saki, N., Ahmadvand, M., Asghari, F., Salari, F., & Rahim, F. (2015) · PubMed · doi:10.22074/cellj.2015.1 · Cited by 68 · cited 1×
“IL-10 stimulates STAT3 phosphorylation and stimulates the immunosuppressive environment [17,18].”
BackgroundHale, M. B., Krutzik, P. O., Samra, S. S., Crane, J., & Nolan, G. P. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006756 · Cited by 49 · cited 1×
“IL-6 contributes to the inflammatory responses through phosphorylation of STAT1 and STAT3 [16].”
BackgroundMortarini, R., Vegetti, C., Molla, A., Arienti, F., Ravagnani, F., Maurichi, A., Patuzzo, R., Santinami, M., & Anichini, A. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3323 · Cited by 36 · cited 4×
“Furthermore, decreased T-cell response to cytokines might be related to increased cytokine consumption owing to increased regulatory T cells with a high affinity for IL-2 receptors [13,15].”
BackgroundInfluentialPotter, M. B. (2013) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031912-114436 · Cited by 32 · cited 1×
“Colorectal cancer (CRC) is the third most commonly diagnosed cancer in men and second in women [1,2].”
Background
Cited by
Kartikasari, A. E. R., Huertas, C. S., Mitchell, A., & Plebanski, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.692142 · Cited by 343
JAK-STAT Signalling Pathway in Cancer
Brooks, A. J., & Putoczki, T. (2020) · Cancers · doi:10.3390/cancers12071971 · Cited by 189
“STAT3 signalling in CD103+ conventional dendritic cells also provides an important immunosuppressive function via IL-10 activation.”
BackgroundInfluentialPotential therapeutic effects of curcumin mediated by JAK/STAT signaling pathway: A review
Ashrafizadeh, M., Rafiei, H., Mohammadinejad, R., Afshar, E. G., Farkhondeh, T., & Samarghandian, S. (2020) · Phytotherapy Research · doi:10.1002/ptr.6642 · Cited by 128
Tangeretin: a mechanistic review of its pharmacological and therapeutic effects
Ashrafizadeh, M., Ahmadi, Z., Mohammadinejad, R., & Afshar, E. G. (2020) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2019-0191 · Cited by 89
Dutta, N., Lillehoj, P. B., Estrela, P., & Dutta, G. (2021) · Biosensors · doi:10.3390/bios11030094 · Cited by 77
“showed the similarity between the STAT phosphorylation pattern induced by the regulatory T cell-subset (Treg) specific cytokine milieu between colorectal cancer tumor-microenvironment and peripheral blood [15].”
Background
Metadata
- Authors
- Yun, J. W., Lee, S., Kim, H. M., Chun, S., Engleman, E. G., Kim, H. C., & Kang, E.-S.
- Affiliations
- Samsung Medical Center (KR)
- Seoul National University (KR)
- Samsung (South Korea) (KR)
- Chonnam National University (KR)
- Stanford University (US)
- Corresponding author
- Kim, Hee Cheol
- Kang, Eun-Suk
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2019-08-12
- Volume
- 11
- Issue
- 8
- Pages
- 1157
- ISSN
- 2072-6694 (ISSN-L)
- PMC
- PMC6721561
- OpenAlex
- W2967234356
- Cited by
- 18
- References
- 28
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 3 · 2022: 3 · 2021: 3 · 2020: 4 · 2019: 2
- FWCI
- 1.25
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Cancers (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Global Ph.D. Fellowship (NRF-2016H1A2A1907938)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- colorectal cancer, blood biomarkers, STAT phosphorylation, regulatory T cells, peripheral blood T cells, tumor-infiltrating T cells, cancer screening, immune cell signatures
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.